Search Count: 70
 |
Tead1 In Complex With A Reversible Inhibitor N-[(1S)-2-Hydroxy-1-(1-Methyl-1H-Pyrazol-3-Yl)Ethyl]-2-Methyl-8-[4-(Trifluoromethyl)Phenyl]-2H,8H-Pyrazolo[3,4-B]Indole-5-Carboxamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.93 Å Release Date: 2025-01-22 Classification: TRANSCRIPTION Ligands: GOL, A1IJL, SO4 |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.26 Å Release Date: 2023-09-06 Classification: TRANSFERASE Ligands: 3E8, PG4, PEG |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.72 Å Release Date: 2023-09-06 Classification: TRANSFERASE Ligands: 3E8, EDO, CL |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.14 Å Release Date: 2023-09-06 Classification: TRANSFERASE Ligands: 3E8 |
 |
Focal Adhesion Kinase Catalytic Domain In Complex With 6-[4-(3-Methanesulfonyl-Benzylamino)-5-Trifluoromethyl-Pyrimidin-2-Ylamino]-3,4-Dihydro-1H-Quinolin-2-One
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.36 Å Release Date: 2021-02-10 Classification: TRANSFERASE Ligands: P4N |
 |
Focal Adhesion Kinase Catalytic Domain In Complex With N-Methyl-N-(3-{[2-(2-Oxo-1,2,3,4-Tetrahydro-Quinolin-6-Ylamino)-5-Trifluoromethyl-Pyrimidin-4-Ylamino]-Methyl}-Pyridin-2-Yl)-Methanesulfonamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.78 Å Release Date: 2021-02-10 Classification: TRANSFERASE Ligands: P7N, NA, SO4 |
 |
Focal Adhesion Kinase Catalytic Domain In Complex With N-Methyl-N-(2-{[2-(2-Oxo-2,3-Dihydro-1H-Indol-5-Ylamino)-5-Trifluoromethyl-Pyrimidin-4-Ylamino]-Methyl}-Phenyl)-Methanesulfonamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.93 Å Release Date: 2021-02-10 Classification: TRANSFERASE Ligands: P9K |
 |
Focal Adhesion Kinase Catalytic Domain In Complex With N-Methyl-N-(3-{[2-(2-Oxo-2,3-Dihydro-1H-Indol-5-Ylamino)-Pyrimidin-4-Ylamino]-Methyl}-Pyridin-2-Yl)-Methanesulfonamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.54 Å Release Date: 2021-02-10 Classification: TRANSFERASE Ligands: PKE, SO4 |
 |
Focal Adhesion Kinase Catalytic Domain In Complex With 5-{4-[(Pyridin-3-Ylmethyl)-Amino]-5-Trifluoromethyl-Pyrimidin-2-Ylamino}-1,3-Dihydro-Indol-2-One
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.81 Å Release Date: 2021-02-10 Classification: TRANSFERASE Ligands: PVT, SO4 |
 |
Focal Adhesion Kinase Catalytic Domain In Complex With 4-{[4-{[(1R,2R)-2-(Dimethylamino)Cyclopentyl]Amino}-5-(Trifluoromethyl)Pyrimidin-2-Yl]Amino}-N-Methylbenzenesulfonamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.92 Å Release Date: 2021-02-10 Classification: TRANSFERASE Ligands: P1E, SO4 |
 |
Focal Adhesion Kinase Catalytic Domain In Complex With N-Methyl-N-{3-[(2-Phenylamino-5-Trifluoromethyl-Pyrimidin-4-Ylamino)-Methyl]-Pyridin-2-Yl}-Methanesulfonamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.30 Å Release Date: 2021-02-10 Classification: TRANSFERASE Ligands: Q2H, SO4 |
 |
Crystal Structure Of Human Methionine Aminopeptidase-2 In Complex; With An Inhibitor (S)-3-Hydroxy-2-Oxo-1-(2-Oxo-1,2,3,4-Tetrahydro-Quinolin-6-Yl)-Pyrrolidine-3-Carboxylic Acid 3-Chloro-5-Fluoro-Benzylamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.80 Å Release Date: 2019-05-01 Classification: HYDROLASE Ligands: EDO, DMS, GOL, HZK, MN |
 |
Crystal Structure Of Human Methionine Aminopeptidase-2 In Complex With An Inhibitor (S)-3-Hydroxy-2-Oxo-1-Phenyl-Pyrrolidine-3-Carboxylic Acid 3-Chloro-5-Fluoro-Benzylamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.79 Å Release Date: 2019-05-01 Classification: HYDROLASE Ligands: EDO, GOL, HZW, MN |
 |
Crystal Structure Of Human Methionine Aminopeptidase-2 In Complex With An Inhibitor 2-Oxo-1-Phenyl-Pyrrolidine-3-Carboxylic Acid (2-Thiophen-2-Yl-Ethyl)-Amide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.08 Å Release Date: 2019-05-01 Classification: HYDROLASE Ligands: GOL, K4K, MN |
 |
Crystal Structure Of Human Methionine Aminopeptidase-2 In Complex With An Inhibitor 5-Chloro-Quinolin-8-Ol
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.17 Å Release Date: 2019-05-01 Classification: HYDROLASE Ligands: GOL, HZQ, MN |
 |
Crystal Structure Of Human Methionine Aminopeptidase-2 In Complex With An Inhibitor 5,6-Difluoro-3-(2-Isopropoxy-4-Piperazin-1-Yl-Phenyl)-1H-Indole-2-Carboxylic Acid Amide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.80 Å Release Date: 2019-05-01 Classification: HYDROLASE Ligands: EDO, GOL, DMS, HZE, MN |
 |
Crystal Structure Of Human Methionine Aminopeptidase-2 In Complex With An Inhibitor Thiophene-2-Sulfonic Acid (4-Fluoro-Benzyl)-(4H-[1,2,4]Triazol-3-Ylmethyl)-Amide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.62 Å Release Date: 2019-05-01 Classification: HYDROLASE Ligands: EDO, HZT, TBU, MN |
 |
Estimation Of Protein-Ligand Unbinding Kinetics Using Non-Equilibrium Targeted Molecular Dynamics Simulations
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.49 Å Release Date: 2019-01-30 Classification: CHAPERONE Ligands: D4W |
 |
Estimation Of Relative Drug-Target Residence Times By Random Acceleration Molecular Dynamics Simulation
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.20 Å Release Date: 2018-05-30 Classification: CHAPERONE Ligands: B5Q |
 |
Estimation Of Relative Drug-Target Residence Times By Random Acceleration Molecular Dynamics Simulation
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.67 Å Release Date: 2018-05-30 Classification: CHAPERONE Ligands: PU1 |